Intranasal Civamide for Episodic Cluster Headache

Completed · Phase 3 · Has a placebo group

Conditions studied: Episodic Cluster Headache

In brief

This is a 49-day study to evaluate the effectiveness of Intranasal Civamide (Zucapsaicin) in the treatment of an episodic cluster headache period compared to placebo (medically inactive substance which does not contain any active ingredients).

Key facts

Study ID

NCT00069082

Run by

Winston Laboratories

People needed

2

Starts

2003-08-01

Expected to finish

2004-01-01

Last updated by the study team

2011-06-10

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• San Francisco Clinical Research Center — San Francisco, California, United States
• California Medical Clinic for Headache — Santa Monica, California, United States
• Colorado Neurology and Headache Clinic — Denver, Colorado, United States
• Diamond Headache Clinic — Chicago, Illinois, United States
• New York Headache Center — New York, New York, United States
• Cleveland Clinic Foundation — Cleveland, Ohio, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.